ClinicalTrials.gov
public full text
Public Domain
A 6-Month Extension Study of OTO-104 in Meniere's Disease
This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104-201102 (Phase 2b study of OTO-104) or 104-201506 (Phase 3 study of OTO-104) in order to be eligible for this open-label extension study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease#1075591
- A Study of a Mastoid Device in Subjects With Ménière's Disease#1171734
- Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease#913990
- Observation of MRI‐Based Endolymphatic Hydrops and Clinical Symptoms in Patients With Definite Meniere′s Disease Over Time: A Case Series#965634
- Use of ISO CLNP in TUBA Environments#131803
Record · ID 903048
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive